docking@grid validation
DESCRIPTION
Docking@Grid ANR meeting - 28/10/2008. Docking@Grid validation. L. Brillet, S. Roy (CEA Grenoble - DSV/iRTSV/CMBA). CEA Grenoble - DSV/iRTSV/CMBA (C. Barette, L. Lafanechère) et LTS (R. Prudent, C. Cochet) Laboratoire d’infochimie, ULP, Strasbourg (S. Conilleau , D. Horvath) - PowerPoint PPT PresentationTRANSCRIPT
1/18L. Brillet (CEA) – Docking@Grid ANR meeting – META’08 Hammamet
Docking@Grid validationDocking@Grid validation
Docking@Grid ANR meeting - 28/10/2008
• CEA Grenoble - DSV/iRTSV/CMBA (C. Barette, L. Lafanechère) et LTS (R. Prudent, C. Cochet)
• Laboratoire d’infochimie, ULP, Strasbourg (S. Conilleau , D. Horvath)
• LIFL, Lille (team of E.-G. Talbi)
L. Brillet, S. Roy (CEA Grenoble - DSV/iRTSV/CMBA)
2/18L. Brillet (CEA) – Docking@Grid ANR meeting – META’08 Hammamet
Introduction
folding
redocking of PDB complexes
comparison with classical docking programs
activity prediction
DOCKING@GRID EVALUATIONDOCKING@GRID EVALUATION
1. Preparation of the PDB complexes
2. Evaluation with the protein kinase CK2 – comparison with Gold
3/18L. Brillet (CEA) – Docking@Grid ANR meeting – META’08 Hammamet
ThrombinCK2 HIV-RT
reference coordinates for ligands superimposition of the complexes’ structures
preparation of the target H, charges, atomic types, file format, active site
preparation of the ligands corrections, H, charges, atomic types, file format
PREPARATION OF THE COMPLEXESPREPARATION OF THE COMPLEXES
3 families of PDB complexes redocking :
3BQC.pdb (human)23 ligands (human + maize)
1RT1.pdb11 ligands
1XM1.pdb10 ligands
Tools : Chimera, MOE, VegaZZ, ChemAxon
4/18L. Brillet (CEA) – Docking@Grid ANR meeting – META’08 Hammamet
Evaluation with the protein kinase CK2
ATP or GTPProtein – substrate
phosphate
+ 300 substrates
CK2 abnormal expression: inflammation (viral) infection cancer
PROTEIN KINASE CK2PROTEIN KINASE CK2
5/18L. Brillet (CEA) – Docking@Grid ANR meeting – META’08 Hammamet
in vitro activity in vivo activity selectivity SAR
DatabaseJChemBase (ChemAxon)
CK2 BIOLOGICAL DATACK2 BIOLOGICAL DATA
CEA Grenoble, DSV/iRTSV/LTS: R. Prudent, C. Cochet• Expanding the chemical diversity of CK2 inhibitors, Prudent et al., 2008, Mol. Cell.
Biochem.• Salicylaldehyde derivatives as new protein kinase CK2 inhibitors, Prudent et al., 2008, Bioch. Biophys. Acta
Evaluation with the protein kinase CK2
CEA Grenoble, DSV/iRTSV/CMBA: C. Barette, L. Lafanechère
HTS screening: ~ 12 000 compounds
post HTS studies: 5 groups of actives / inactives structural analogues (~ 100 compounds)
6/18L. Brillet (CEA) – Docking@Grid ANR meeting – META’08 Hammamet
EVALUATION WITH CK2 – COMPARISON DOCKING@GRID - GOLD
EVALUATION WITH CK2 – COMPARISON DOCKING@GRID - GOLD
Docking@Grid Gold (CCDC)
• co-cristallised ligands • set of analogues (known activity)• CMBA library (CEA): 35000 comp.
• co-cristallised ligands • others ?
docking docking
results resultsComparison ?
1 protein conformation
Hits selection in vitro tests
7/18L. Brillet (CEA) – Docking@Grid ANR meeting – META’08 Hammamet
Gold Glide FlexX
PRELIMINARY STUDIESPRELIMINARY STUDIESComparison Docking@Grid - Gold
Revue of the litterature (docking, evaluation of the docking programs)
Training in D. Rognan’s laboratory (Strasbourg)
Choice of a docking program
8/18L. Brillet (CEA) – Docking@Grid ANR meeting – META’08 Hammamet
1. Bibliography2. Preparation of the target3. Preparation of the library4. Design of the screening parameters 5. Screening of the library6. Post-processing / results analysis
VIRTUAL SCREENING ON CK2 WITH GOLD
VIRTUAL SCREENING ON CK2 WITH GOLD
Developed strategy:
Comparison Docking@Grid - Gold
9/18L. Brillet (CEA) – Docking@Grid ANR meeting – META’08 Hammamet
33 publications 25 cristallised inhibitors-CK2 complexes (PDB)
- structure
- flexibility
- water molecules ?
- binding modes / interactions
BIBLIOGRAPHYBIBLIOGRAPHYComparison Docking@Grid - Gold
information about the active site:
10/18L. Brillet (CEA) – Docking@Grid ANR meeting – META’08 Hammamet
emodin, 3BQC.pdb
Lys68
green = hydrophobicpink = polar
11/18L. Brillet (CEA) – Docking@Grid ANR meeting – META’08 Hammamet
PREPARATION OF THE TARGETPREPARATION OF THE TARGET
Comparison Docking@Grid - Gold
Preparation
Choice of the
conformation
12/18L. Brillet (CEA) – Docking@Grid ANR meeting – META’08 Hammamet
Unique ID
Protonation pH 7.4
Tautomers
Standardisation
2D 3D
PREPARATION OF THE LIBRARYPREPARATION OF THE LIBRARY
xx
xx
x
Comparison Docking@Grid - Gold
automated procedure:
13/18L. Brillet (CEA) – Docking@Grid ANR meeting – META’08 Hammamet
DESIGN OF THE SCREENING PARAMETERS
DESIGN OF THE SCREENING PARAMETERS
1 - Docking of PDB complexes
check the pose (RMSD < 2A ?)
Comparison Docking@Grid - Gold
Docking protocole variations with Gold :
- water molecule n°2
- flexibility of the lateral chains
- number of genetic operations for each genetic algorithm run
- number of genetic algorithm runs per ligand
failures : no flexibility of the hinge region
good success rate
14/18L. Brillet (CEA) – Docking@Grid ANR meeting – META’08 Hammamet
2 - Docking of a small set of actives / inactives
check the enrichment in actives
actives
inactives
% of actives
% of compounds ranked by score
100%
100%
random
enrichment
Comparison Docking@Grid - Gold
DESIGN OF THE SCREENING PARAMETERS
DESIGN OF THE SCREENING PARAMETERS
15/18L. Brillet (CEA) – Docking@Grid ANR meeting – META’08 Hammamet
POST-PROCESSING / RANKING OF THE MOLECULES
POST-PROCESSING / RANKING OF THE MOLECULES
Strategies:
based on interaction fingerprints
+ diversity analysis
Comparison Docking@Grid - Gold
based on a consensus of scoring
functions
Optimizing Fragment and Scaffold Docking by Use of Molecular Interaction Fingerprints, G. Marcou & D. Rognan, 2007, J. Chem. Inf. Model.
16/18L. Brillet (CEA) – Docking@Grid ANR meeting – META’08 Hammamet
EVALUATION WITH CK2 – COMPARISON DOCKING@GRID - GOLD
EVALUATION WITH CK2 – COMPARISON DOCKING@GRID - GOLD
Docking@Grid Gold (CCDC)
• co-cristallised ligands • set of analogues (known activity)• CMBA library (CEA): 35000 comp.
• co-cristallised ligands • others ?
docking docking
results resultsComparison ?
1 protein conformation
Hits selection in vitro tests
17/18L. Brillet (CEA) – Docking@Grid ANR meeting – META’08 Hammamet
CEA: CMBA (C. Barette, L. Lafanechère), LTS (R. Prudent, C. Cochet, V. Moucadel),
Laboratoire d’Infochimie (ULP, Strasbourg): S. Conilleau, D. Horvath, G. Marcou
Bioinformatique du Médicament, Laboratoire de Pharmacochimie et de la Communication Cellulaire (ULP, Illkirch): D. Rognan and his team
CEA: GIPSE (C. Charavay, V. Dorffer, J.-P. Eynar), IBS (A. Thomas)
M. Lopez-Ramos (Institut Curie, Paris), J.-N. Denis (UJF), D. Giganti (Institut Pasteur, Paris)
Laboratoire d’Informatique Fondamentale de Lille: team of E.-G. Talbi
Conclusion
THANKSTHANKS
18/18L. Brillet (CEA) – Docking@Grid ANR meeting – META’08 Hammamet
Docking@Grid validationDocking@Grid validation
Docking@Grid ANR meeting - 28/10/2008
• CEA Grenoble - DSV/iRTSV/CMBA (C. Barette, L. Lafanechère) et LTS (R. Prudent, C. Cochet)
• Laboratoire d’infochimie, ULP, Strasbourg (D. Horvath, S. Conilleau)
• LIFL, Lille (team of E.-G. Talbi)
L. Brillet, S. Roy (CEA Grenoble - DSV/iRTSV/CMBA)